Current views on the pathophysiology and investigations of thrombotic disorders.
D000990:Antithrombin III / Q000032:analysis / Q000502:physiology; D001157:Arterial Occlusive Diseases / Q000503:physiopathology; D001779:Blood Coagulation Factors / Q000032:analysis / Q000276:immunology / Q000502:physiology; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005342:Fibrinolysis; D006023:Glycoproteins / Q000502:physiology; D015844:Heparin Cofactor II; D006801:Humans; D016682:Lupus Coagulation Inhibitor; D008833:Microcirculation; D010314:Partial Thromboplastin Time; D011486:Protein C / Q000502:physiology; D017293:Protein S; D013924:Thrombophlebitis / Q000209:etiology; D013927:Thrombosis / Q000209:etiology / Q000503:physiopathology*
D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; D006023:Glycoproteins; D016682:Lupus Coagulation Inhibitor; D011486:Protein C; D017293:Protein S; D015844:Heparin Cofactor II; D000990:Antithrombin III